Looking to improve overall health at a cellular level and promote healthy aging
Inclusion on the 503A bulks list is not the same as FDA approval of a drug
1998 foundational paper reported GHS-R1a binding affinity in the low-nanomolar range and growth hormone release from primary rat pituitary cells, anesthetized rats, and conscious swine at potencies comparable to GHRP-6, while plasma ACTH, cortisol, prolactin, FSH, LH, and TSH were not detectably elevated at doses greater than 200-fold above the GH ED50 in those animal preparations [3]
Besides, patients who received RPH + sMMH therapy have showed benefits on the quality of daily life and constipation symptoms, patients who received RPH + sMMH therapy, showed higher quality of life, and lighter degree of constipation
Abstract Cancer represents the main cause of death worldwide